Topic Highlight
Copyright ©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Jun 28, 2014; 20(24): 7544-7554
Published online Jun 28, 2014. doi: 10.3748/wjg.v20.i24.7544
Hepatitis C virus associated glomerulopathies
Abdullah Ozkok, Alaattin Yildiz
Abdullah Ozkok, Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, Istanbul Medeniyet University, Istanbul 34730, Turkey
Alaattin Yildiz, Division of Nephrology, Department of Internal Medicine, Istanbul School of Medicine, Istanbul University, Istanbul 34093, Turkey
Author contributions: Ozkok A searched the literature, gathered the information, and wrote the paper; Yildiz A designed and wrote the paper.
Correspondence to: Alaattin Yildiz, MD, Division of Nephrology, Department of Internal Medicine, Istanbul School of Medicine, Istanbul University, Capa, Topkapi, Istanbul 34093, Turkey. alayildiz@yahoo.com
Telephone: +90-542-2427320 Fax: +90-212-4142022
Received: October 24, 2013
Revised: February 8, 2014
Accepted: April 1, 2014
Published online: June 28, 2014
Core Tip

Core tip: Hepatitis C virus (HCV) infection is found to be frequently associated with proteinuria, various glomerulopathies and higher risk of end-stage renal disease. HCV positivity has been linked to decreased graft and patient survivals after kidney transplantation. Treatment of HCV infection is a great clinical challenge in kidney transplant patients and in patients with diminished kidney function. In this review, we aimed to review kidney involvement in the course of HCV infection and treatment of HCV-associated glomerulopathies.